Sfondo Header
L'angolo del dottorino
Indice
Cerca nel sito... Ricerca avanzata
✖

Cardiac arrest and sudden death

Cardiac arrest is the cessation of effective circulation and represents a potentially reversible emergency; sudden death, by contrast, describes an unexpected fatal outcome whose cause must be established. The two terms are closely related but not interchangeable. A patient may survive cardiac arrest, whereas a sudden death may result from a cardiac cause or from other acute conditions. This distinction guides both emergency treatment and clinical and family investigation.

This chapter brings together problems that unfold over different time scales: recognizing the event, supporting perfusion and oxygenation, treating the responsible mechanism, limiting injury after resuscitation and preventing recurrences or new events in the family. The introductory page presents these relationships and their clinical significance; the dedicated monographs explore cardiac arrest, sudden cardiac death, events in young people and sudden arrhythmic death syndrome, while keeping emergency management distinct from definition of etiology.

Definitions and interpretation of context

During cardiac arrest, cardiac output is insufficient to maintain cerebral and systemic perfusion. The patient becomes unresponsive and does not breathe normally, although agonal respiratory movements may persist. The presence of electrical activity on the monitor does not guarantee effective mechanical activity. Clinical recognition must therefore precede the search for a complete etiological diagnosis. Speed of rescue is decisive, while definition of the cause continues during and after stabilization.

Sudden cardiac death is commonly defined as an unexpected death attributable to a cardiac cause occurring within a short interval from symptom onset; in witnessed events, one hour is often used, whereas in unwitnessed events the last observation alive and stable within 24 hours is frequently considered. These are operational conventions that vary among studies and registries and do not by themselves establish an arrhythmic mechanism. Classification accuracy also depends on clinical information and postmortem examination.

Myocardial infarction may cause cardiac arrest, but the two events are not synonymous. Infarction indicates ischemic injury to the myocardium, whereas arrest describes circulatory collapse, which may also occur without coronary occlusion. Likewise, syncope is a transient loss of consciousness due to hypoperfusion with spontaneous recovery and may have many mechanisms. Reconstructing the event prevents indiscriminate use of terms that imply very different investigations, treatment and risk.

Interpretation of epidemiological data also requires clear denominators. Cardiac arrests treated by the emergency medical system, estimated total events and deaths classified as cardiac do not represent the same population. Survival to discharge, return of circulation and neurological outcome describe different endpoints. Comparisons between areas or institutions should therefore specify definitions, completeness of ascertainment and case characteristics. An apparent difference may depend on the recording system as well as on the quality of resuscitation.

Location and circumstances modify both the probability of causes and the ability to document them. In out-of-hospital cardiac arrest, the presence of witnesses, access to emergency services and availability of defibrillation are important; in hospital, monitoring and preceding signs of deterioration may be available. The first recorded rhythm does not always match the rhythm that initiated the event because arrhythmias evolve over time. Late-recorded asystole does not prove that ventricular fibrillation was not present initially.

Sudden cardiac death in the young requires particular attention to inherited diseases, congenital anomalies and non- atherosclerotic causes, without excluding acquired etiologies. Age limits used in research are not uniform and should be specified when epidemiological data are compared. Sudden arrhythmic death syndrome concerns deaths in which adequate postmortem and toxicological examination does not identify a cause, while maintaining suspicion of an electrical disorder. It is not a diagnosis to be assigned simply because no autopsy was performed.

Terminal mechanisms and underlying causes

The operational distinction between shockable and non-shockable rhythms guides initial treatment. Ventricular fibrillation and pulseless ventricular tachycardia require shock when recognized; asystole and pulseless electrical activity require resuscitation and investigation of causes, without defibrillation being indicated solely because collapse has occurred. This classification describes the rhythm present but does not exhaust the etiology. The same disease may produce different configurations at different points during the event.

Ventricular fibrillation causes disorganized activation incompatible with coordinated contraction. It may be triggered by ischemia, scar, cardiomyopathy or electrical disorders, sometimes through particular premature beats. In pulseless electrical activity, by contrast, an organized rhythm does not produce effective circulation, often because of mechanical or metabolic problems or severe hypoxia. The monitor appearance must therefore be integrated with the clinical picture and the search for correctable conditions.

Cardiac causes include coronary artery disease, cardiomyopathies, myocarditis, significant valvular disease and congenital anomalies. Fibrosis, dysfunction and conduction abnormalities may create a vulnerable substrate even without an acute ischemic event. In channelopathies, risk may be present despite apparently normal structure, making echocardiography alone insufficient to exclude disease. Age, preceding symptoms and circumstances help guide the pathway without replacing verification of hypotheses.

Hypoxia, hemorrhage or other hypovolemia, pulmonary embolism, tamponade, tension pneumothorax, electrolyte abnormalities and toxicity are examples of reversible or treatable causes to consider during resuscitation. Their probability depends on the context and available data. A cardiac arrest generically attributed to the heart may have an extracardiac origin, and management limited to the rhythm risks overlooking the problem preventing recovery. Life support and etiological correction must proceed together.

Drugs and substances may act through QT prolongation, slowed conduction, ischemia, respiratory depression or interactions. The distinction between a wholly acquired cause and a predisposition unmasked by exposure is not always immediate. An event that appears reversible requires assessment of residual risk after correction, particularly if persistent abnormalities or a family history are present. The mere presence of a trigger does not demonstrate that all underlying vulnerability has been eliminated.

Recognition and continuity of resuscitation

The chain of survival links recognition, activation of emergency services, resuscitation, defibrillation and subsequent care. No link makes the others unnecessary. The 2025 recommendations emphasize rapid activation of the emergency system for an unresponsive person, with telephone assistance in assessment and resuscitation. Gasping and initial convulsive movements may mislead an observer: they should not automatically be interpreted as effective breathing or proof of an exclusively neurological cause.

Chest compressions sustain limited but essential blood flow to the heart and brain. In adults, quality includes a rate of 100–120 per minute, depth of about 5–6 centimeters, complete chest recoil and minimization of interruptions. Ventilations are incorporated according to rescuer skill and protocol, avoiding excesses that may impair hemodynamics. A rescuer unable to provide ventilation should still begin compressions following dispatcher instructions rather than forgoing resuscitation.

The automated external defibrillator analyzes the rhythm and guides shock delivery when indicated. Its usefulness depends on actual availability and the time required to bring it to the patient. Retrieval, preparation and analysis should be organized to minimize pauses in compressions. A shock may terminate a shockable arrhythmia but does not replace resuscitation, and a “no shock advised” decision does not mean that the patient is not in cardiac arrest.

Advanced life support integrates airway management, monitoring, vascular access, medications and identification of reversible causes. Procedures should be performed while maintaining resuscitation quality as the priority. Ultrasound and capnography can provide useful information in appropriate hands but should not cause prolonged interruptions or be interpreted in isolation. Details of the pathways for each rhythm are developed in the monograph on cardiac arrest, because they depend on the situation and available resources.

Return of spontaneous circulation does not mean complete recovery. The patient may remain unstable, hypoxemic, comatose or susceptible to further arrhythmias. The transition from resuscitation to subsequent care should preserve timing, rhythms, interventions and circumstances of the event, because this information influences diagnosis and prognosis. Effective handover includes continuity of monitoring and communication of the clinical picture, not merely the observation that the pulse has returned.

Post-arrest care and assessment of outcomes

Post-cardiac arrest syndrome includes hypoxic-ischemic brain injury, myocardial dysfunction, the systemic ischemia- reperfusion response and persistence of the precipitating cause. Oxygenation, ventilation, perfusion and temperature should be controlled while avoiding unfavorable extremes. The aim is to support recovery and treat the responsible mechanism, not merely to obtain temporarily normal parameters. Needs may change rapidly and require monitoring and reassessment in an appropriate setting.

Urgent coronary assessment is a priority in the presence of clear signs of occlusion, such as a presentation consistent with ST-segment elevation, or strong clinical suspicion associated with hemodynamic or electrical instability. In stable patients without these features, cardiac arrest alone does not mandate the same immediate strategy for everyone. Imaging and investigations should also consider non-coronary causes, including pulmonary embolism, hemorrhage and aortic disease when the context suggests them. The choice is based on the totality of available data.

The 2025 ERC-ESICM recommendations emphasize active fever prevention in patients who remain comatose, with temperature maintained at no more than 37.5 °C according to the clinical pathway. Temperature control requires monitoring and management of treatment effects without reducing all neurological care to a single value. Oxygenation, ventilation, blood pressure, seizures and metabolic factors remain important. The strategy should be consistent with contemporary evidence and the individual situation.

Neurological prognosis requires a multimodal approach integrating clinical examination, electrophysiology, biomarkers and imaging, while considering timing and confounders. Sedation, neuromuscular blockade, temperature and organ dysfunction may alter results. An isolated early sign should not determine irreversible conclusions about recovery. Prognostic estimation must be separated from broader decisions about goals of care, which include pre-existing conditions and the patient's wishes when known.

Survival should be assessed together with cognitive function, independence and quality of life. Memory disorders, fatigue, anxiety and psychological consequences may persist even when motor recovery appears good. Before discharge, physical and non-physical needs should be identified and rehabilitation and follow-up planned. Family members may also need support after the event. Good post-arrest care continues beyond cardiovascular stabilization and beyond the end of intensive care.

Investigation of the cause in survivors and after death

In survivors, serial ECGs, resuscitation documentation, blood tests, coronary imaging and structural assessment form the basis of the investigation. An abnormal QT interval or depressed function immediately after resuscitation may be transient and require reassessment. Exercise testing, pharmacological provocation and electrophysiological study are selected according to clinical suspicion. A diagnosis of idiopathic ventricular fibrillation presupposes an adequate investigation and remains open to revision if new information emerges.

After a sudden death, the quality of the postmortem examination affects both attribution of the cause and family prevention. Appropriate autopsy, histology and toxicology may identify heart disease, extracardiac causes or exposures, avoiding generic classifications. The absence of a macroscopic lesion does not automatically establish a channelopathy, while a mild anatomical finding does not necessarily prove causality. Assessment by experienced professionals is particularly important in young people and families with multiple events.

Preservation of suitable samples may allow a molecular autopsy when the presentation suggests an inherited cause. This term refers to genetic investigation, not a substitute for anatomical and toxicological autopsy. Gene selection should be guided by phenotype or circumstances, with attention to validity of the associations. Extensive sequencing without a hypothesis may produce uncertain variants and complicate counseling without providing a reliable explanation of the death.

Family screening integrates pedigree, clinical history, ECG and relevant investigations. When a causal variant is identified, cascade testing allows targeted assessment; a variant of uncertain significance should not be treated as a predictive diagnosis. Even without a defined molecular cause, clinical investigation may identify phenotypes in relatives. Assessment should be coordinated and open to revision because some diseases become apparent only with age or new family information.

Communication of the cause requires precision in distinguishing certainty, probability and absence of an explanation. “Cardiac death”, “arrhythmic death” and “unexplained death” are not equivalent expressions. Overconfident classification may misdirect prevention, while a classification that is too generic may miss diagnostic opportunities. Documenting the limits of the investigations allows professionals who later follow the family to understand which hypotheses were excluded and which remain open.

Prevention of recurrence and organization of protection

Secondary prevention concerns those who have already experienced an arrhythmia or cardiac arrest and depends on the mechanism, reversibility and residual disease. A defibrillator is fundamental in many situations involving ventricular risk, but it is not a universal response to every cardiac arrest, especially when the cause is non-arrhythmic or completely correctable. Medications, revascularization, ablation and treatment of the heart disease may be required together with the device. The decision should explain which risk is being prevented and by which means.

The presence of a potentially reversible cause should be discussed concretely: which factor was corrected, how likely a new exposure is, and whether a predisposing substrate remains. An isolated electrolyte disturbance in a healthy heart is not equivalent to the same abnormality in cardiomyopathy or long QT syndrome. Reversibility therefore cannot be a label applied retrospectively to automatically exclude all protection. The reasoning should be documented and reassessment planned when recovery changes the clinical picture.

Primary prevention identifies people at high risk before the event. Ventricular function, type of cardiomyopathy, scar, arrhythmias, genotype and other factors carry different weights in different diseases. A reduced ejection fraction is important in many pathways but does not capture every possible cause of sudden death. In inherited electrical disorders, risk may be significant with preserved function. Criteria should therefore be applied to the specific condition without transferring the same threshold to every phenotype.

Population prevention includes treatment of cardiovascular risk factors and recognition of disease, but also the ability to respond to an unpredictable event. Resuscitation training, telephone assistance and defibrillator accessibility reduce the time without circulation or without treatment of the arrhythmia. A device that is present but cannot be reached quickly provides limited protection. Registries, time analysis and event review help identify organizational problems that do not emerge from protocol descriptions alone.

In hospital, recognition of deterioration, escalation of care and continuity of information may prevent some arrests or improve the response. Review should distinguish delays in recognition, quality of resuscitation, treatment of the cause and subsequent care, avoiding attribution of the outcome to a single step. Process indicators and clinical outcomes should be interpreted in relation to the population served. Event analysis is useful when it produces concrete changes in the system rather than merely formal recording.

The individual pathway ends with an understandable plan for therapy, follow-up, symptoms and daily life, while the family pathway may continue even after a fatal outcome. Distinguishing cardiac arrest, arrhythmic mechanism and underlying cause makes it possible to connect emergency response and prevention correctly. The pages in this chapter explore these levels without overlapping them: acting immediately on the event, understanding its origin and protecting those who remain at risk are different objectives, each necessary for comprehensive management.

References
  1. Zeppenfeld K et al. 2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. European Heart Journal. 2022;43(40):3997-4126.
  2. Soar J et al. European Resuscitation Council Guidelines 2025 Adult Advanced Life Support. Resuscitation. 2025;215(Suppl 1):110769.
  3. Merino JL et al. Practical compendium of antiarrhythmic drugs: a clinical consensus statement of the European Heart Rhythm Association of the European Society of Cardiology. Europace. 2025;27(8):euaf076.
  4. Tisdale JE et al. Drug-Induced Arrhythmias: A Scientific Statement From the American Heart Association. Circulation. 2020;142(15):e214-e233.
  5. Gorenek B et al. Cardiac arrhythmias in acute coronary syndromes: position paper from the joint EHRA, ACCA, and EAPCI task force. Europace. 2014;16(11):1655-1673.
  6. Brignole M et al. 2018 ESC Guidelines for the diagnosis and management of syncope. European Heart Journal. 2018;39(21):1883-1948.
  7. Wilde AAM et al. European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) Expert Consensus Statement on the state of genetic testing for cardiac diseases. Europace. 2022;24(8):1307-1367.
  8. Lampert R et al. 2024 HRS expert consensus statement on arrhythmias in the athlete: Evaluation, treatment, and return to play. Heart Rhythm. 2024;21(10):e151-e252.
  9. Stiles MK et al. 2020 APHRS/HRS expert consensus statement on the investigation of decedents with sudden unexplained death and patients with sudden cardiac arrest, and of their families. Journal of Arrhythmia. 2021;37(3):481-534.
  10. Nolan JP et al. European Resuscitation Council and European Society of Intensive Care Medicine Guidelines 2025 Post-Resuscitation Care. Resuscitation. 2025;215(Suppl 1):110809.
  11. Resuscitation Council UK. Adult basic life support Guidelines. Resuscitation Guidelines. 2025.
  12. Resuscitation Council UK. Post-resuscitation care Guidelines. Resuscitation Guidelines. 2025.

Nota informativa: le informazioni contenute in questa pagina hanno esclusivamente finalità informative e divulgative e non sostituiscono il parere, la diagnosi o il trattamento di un medico. In caso di necessità, rivolgersi sempre a un professionista sanitario qualificato.

Trasparenza sull'intelligenza artificiale: questa pagina è stata realizzata con il supporto di strumenti di intelligenza artificiale, utilizzati come ausilio nella produzione e nell'elaborazione dei contenuti.